{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:55:07Z","timestamp":1783551307262,"version":"3.55.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004919","name":"King Abdulaziz City for Science and Technology","doi-asserted-by":"publisher","award":["14-Bio883-03"],"award-info":[{"award-number":["14-Bio883-03"]}],"id":[{"id":"10.13039\/501100004919","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11033-022-07267-7","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T19:40:38Z","timestamp":1650570038000},"page":"4321-4339","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Anticancer activity of chicken cathelicidin peptides against different types of cancer"],"prefix":"10.1007","volume":"49","author":[{"given":"Maged Mostafa","family":"Mahmoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modhi","family":"Alenezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Al-Hejin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turki S.","family":"Abujamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadwa","family":"Aljoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulwahab","family":"Noorwali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim A.","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alkhaled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3302-6579","authenticated-orcid":false,"given":"Haitham A.","family":"Yacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,21]]},"reference":[{"key":"7267_CR1","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3892\/ijo.2015.2887","volume":"46","author":"K Kuroda","year":"2015","unstructured":"Kuroda K, Fukuda T, Isogai H, Okumura K, Krstic-Demonacos M, Isogai E (2015) Antimicrobial peptide FF\/CAP18 induces apoptotic cell death in HCT116 colon cancer cells via changes in the metabolic profile. Int J Oncol 46:1516\u20131526. doi:https:\/\/doi.org\/10.3892\/ijo.2015.2887","journal-title":"Int J Oncol"},{"key":"7267_CR2","doi-asserted-by":"crossref","unstructured":"Parvy J-P, Yu Y, Dostalova A, Kondo S, Kurjan A, Bulet P, Lema\u00eetre B, Vidal M, Cordero JB (2019) The antimicrobial peptide defensin cooperates with tumour necrosis factor to drive tumour cell death in Drosophila. eLife 8, e45061","DOI":"10.7554\/eLife.45061"},{"issue":"8","key":"7267_CR3","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/ijc.25489","volume":"127","author":"WK Wu","year":"2010","unstructured":"Wu WK, Wang G, Coffelt SB, Betancourt AM, Lee CW, Fan D et al (2010) Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications. Int J Cancer 127(8):1741\u20131747. doi:https:\/\/doi.org\/10.1002\/ijc.25489","journal-title":"Int J Cancer"},{"issue":"9","key":"7267_CR4","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1016\/j.bbamem.2014.01.016","volume":"1838","author":"G Wang","year":"2014","unstructured":"Wang G, Mishra B, Epand RF, Epand RM (2014) High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments. Biochim Biophys Acta 1838(9):2160\u20132172","journal-title":"Biochim Biophys Acta"},{"key":"7267_CR5","doi-asserted-by":"crossref","unstructured":"Goitsuka R, Chen C-LH, Benyon L, Asano Y, Kitamura D, Cooper MD (2007) Chicken cathelicidin-B1, an antimicrobial guardian at the mucosal M cell gateway. Proc. Natl. Acad. Sci. USA 104, 15063\u201315068","DOI":"10.1073\/pnas.0707037104"},{"key":"7267_CR6","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1074\/jbc.M507180200","volume":"281","author":"Y Xiao","year":"2006","unstructured":"Xiao Y, Cai Y, Bommineni YR, Fernando SC, Prakash O, Gilliland SE, Zhang G (2006) Identification and functional characterization of three chicken cathelicidins with potent antimicrobial activity. J Biol Chem 281:2858\u20132867","journal-title":"J Biol Chem"},{"key":"7267_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2049-1891-3-15","volume":"3","author":"M Achanta","year":"2012","unstructured":"Achanta M, Sunkara LT, Dai G, Bommineni YR, Jiang W, Zhang (2012) G. Tissue expression and developmental regulation of chicken cathelicidin antimicrobial peptides. J Anim Sci Biotechnol 3:15","journal-title":"J Anim Sci Biotechnol"},{"key":"7267_CR8","doi-asserted-by":"crossref","unstructured":"Cuperus T, Van Dijk A, Matthijs MGR, Veldhuizen EJA, Haagsman HP (2016) Protective effect of in ovo treatment with the chicken cathelicidin analog D-CATH-2 against avian pathogenic E. coli. Sci. Rep. 6, 26622","DOI":"10.1038\/srep26622"},{"key":"7267_CR9","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.dci.2013.04.019","volume":"41","author":"T Cuperus","year":"2013","unstructured":"Cuperus T, Coorens M, Van Dijk A, Haagsman HP (2013) Avian host defense peptides. Dev Comp Immunol 41:352\u2013369","journal-title":"Dev Comp Immunol"},{"key":"7267_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12917-016-0866-6","volume":"12","author":"MO Lee","year":"2016","unstructured":"Lee MO, Jang H-J, Rengaraj D, Yang S-Y, Han JY, Lamont SJ, Womack JE (2016) Tissue expression and antibacterial activity of host defense peptides in chicken. BMC Vet Res 12:231","journal-title":"BMC Vet Res"},{"key":"7267_CR11","doi-asserted-by":"crossref","unstructured":"Lee MO, Kim E-H, Jang H-J, Na Park M, Woo H-J, Han JY, Womack JE (2012) Effects of a single nucleotide polymorphism in the chicken NK-lysin gene on antimicrobial activity and cytotoxicity of cancer cells. Proc. Natl. Acad. Sci. USA 109, 12087\u201312092","DOI":"10.1073\/pnas.1209161109"},{"key":"7267_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-981-13-3588-4_1","volume":"1117","author":"M Zasloff","year":"2019","unstructured":"Zasloff M (2019) Antimicrobial Peptides of Multicellular Organisms: My Perspective. Adv Exp Med Biol 1117:3\u20136","journal-title":"Adv Exp Med Biol"},{"key":"7267_CR13","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.molimm.2008.12.015","volume":"46","author":"A Van Dijk","year":"2009","unstructured":"Van Dijk A, Tersteeg-Zijderveld MH, Tjeerdsma-van Bokhoven JL, Jansman AJ, Veldhuizen EJ, Haagsman HP (2009) Chicken heterophils are recruited to the site of Salmonella infection and release antibacterial mature Cathelicidin-2 upon stimulation with. LPS Mol Immunol 46:1517\u20131526","journal-title":"LPS Mol Immunol"},{"key":"7267_CR14","doi-asserted-by":"publisher","first-page":"e0147919","DOI":"10.1371\/journal.pone.0147919","volume":"11","author":"A Van Dijk","year":"2016","unstructured":"Van Dijk A, van Eldik M, Veldhuizen EJ, Tjeerdsma-van Bokhoven HL, de Zoete MR, Bikker FJ, Haagsman HP (2016) Immunomodulatory and anti-inflammatory activities of chicken cathelicidin-2 derived peptides. PLoS ONE 11:e0147919","journal-title":"PLoS ONE"},{"key":"7267_CR15","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.4049\/jimmunol.1501242","volume":"195","author":"M Coorens","year":"2015","unstructured":"Coorens M, Van Dijk A, Bikker F, Veldhuizen EJA, Haagsman HP (2015). Importance of endosomal cathelicidin degradation to enhance DNA-induced chicken macrophage activation. J Immunol 195:3970\u20133977","journal-title":"J Immunol"},{"key":"7267_CR16","doi-asserted-by":"crossref","unstructured":"Coorens M, Schneider VA, de Groot AM, van Dijk A, Meijerink M, Wells JM, Scheenstra MR, Veldhuizen EJ, Haagsman HP 2017 Cathelicidins inhibit escherichia coli\u2013induced tlr2 and tlr4 activation in a viability-dependent manner.J Immunol199(4):1418\u20131428","DOI":"10.4049\/jimmunol.1602164"},{"key":"7267_CR17","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3389\/fmicb.2020.00426","volume":"11","author":"L Peng","year":"2020","unstructured":"Peng L, Du W, Balhuizen M, Haagsman HP, de Haan C, Veldhuizen (2020) E.J.A. Antiviral activity of chicken cathelicidin B1 against influenza A virus. Front Microbiol 11:426","journal-title":"Front Microbiol"},{"key":"7267_CR18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13567-020-00849-y","volume":"51","author":"L Peng","year":"2020","unstructured":"Peng L, Scheenstra MR, van Harten RM, Haagsman HP, Veldhuizen EJ (2020) The immunomodulatory effect of cathelicidin-B1 on chicken macrophages. Vet Res 51:122","journal-title":"Vet Res"},{"key":"7267_CR19","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1159\/000490183","volume":"47","author":"X Chen","year":"2018","unstructured":"Chen X, Zou X, Qi G, Tang Y, Guo Y, Si J, Liang L (2018) Roles and Mechanisms of Human Cathelicidin LL-37 in Cancer. Cell Physiol Biochem 47:1060\u20131073","journal-title":"Cell Physiol Biochem"},{"key":"7267_CR20","first-page":"4301","volume":"61","author":"MV Blagosklonny","year":"2001","unstructured":"Blagosklonny MV, Pardee AB (2001) Exploiting cancer cell cycling for selective protection of normal cells. Cancer Res 61:4301\u20134305","journal-title":"Cancer Res"},{"key":"7267_CR21","doi-asserted-by":"crossref","unstructured":"Nurse P (2002) Cyclin dependent kinases and cell cycle control (Nobel lecture). ChemBioChem 3, 596\u2013603","DOI":"10.1002\/1439-7633(20020703)3:7<596::AID-CBIC596>3.0.CO;2-U"},{"key":"7267_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/00008390-200304000-00003","volume":"13","author":"R Ghosh","year":"2003","unstructured":"Ghosh R, Ott AM, Seetharam D, Slaga TJ, Kumar AP (2003) Cell cycle block and apoptosis induction in a human melanoma cell line following treatment with 2-methoxyoestradiol:. Therapeutic implications? Melanoma Res 13:119\u2013127","journal-title":"Therapeutic implications? Melanoma Res"},{"key":"7267_CR23","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1074\/jbc.273.6.3718","volume":"273","author":"J Johansson","year":"1998","unstructured":"Johansson J, Gudmundsson GH, Rottenberg M, Berndt K, Agerberth B (1998) Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem 273:3718\u20133724. doi:https:\/\/doi.org\/10.1074\/jbc.273.6.3718","journal-title":"J Biol Chem"},{"issue":"Pt 3","key":"7267_CR24","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1042\/0264-6021:3410501","volume":"341","author":"Z Oren","year":"1999","unstructured":"Oren Z, Lerman JC, Gudmundsson GH, Agerberth B, Shai Y (1999) Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: Relevance to the molecular basis for its non-cell-selective activity. Biochem J 341(Pt 3):501\u2013513. doi:https:\/\/doi.org\/10.1042\/0264-6021:3410501","journal-title":"Biochem J"},{"key":"7267_CR25","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2174\/138920306779025611","volume":"7","author":"SR Dennison","year":"2006","unstructured":"Dennison SR, Whittaker M, Harris F, Phoenix DA (2006) Anticancer alpha-helical peptides and structure\/function relationships underpinning their interactions with tumour cell membranes. Curr Protein Pept Sci 7:487\u2013499. doi:https:\/\/doi.org\/10.2174\/138920306779025611","journal-title":"Curr Protein Pept Sci"},{"key":"7267_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.dci.2016.06.012","volume":"65","author":"HA Yacoub","year":"2016","unstructured":"Yacoub HA, Elazzazy A, Mahmoud MM, Baeshen MN, Al-Maghrabi OA, Alkarim S, Ahmed ES, Almehdar HA, Uversky VN (2016). Chicken cathelicidins as potent intrinsically disordered biocides with antimicrobial activity against infectious pathogens. Dev Comp Immunol 65:8\u201324","journal-title":"Dev Comp Immunol"},{"key":"7267_CR27","doi-asserted-by":"publisher","first-page":"12316","DOI":"10.1074\/jbc.M413406200","volume":"280","author":"Y Chen","year":"2005","unstructured":"Chen Y, Mant CT, Farmer SW, Hancock R, Vasil ML, Hodges RS (2005) Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity\/therapeutic index. J Biol Chem 280:12316\u201312329. doi:https:\/\/doi.org\/10.1074\/jbc.M413406200","journal-title":"J Biol Chem"},{"key":"7267_CR28","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1158\/1535-7163","volume":"10","author":"Y Huang","year":"2011","unstructured":"Huang Y, Wang X-F, Wang H-Y, Liu Y, Chen Y (2011) Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural framework. Mol Cancer Ther 10:416\u2013426. doi:https:\/\/doi.org\/10.1158\/1535-7163. MCT-10-0811","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"7267_CR29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1034\/j.1399-302X.2003.00083.x","volume":"18","author":"E Isogai","year":"2003","unstructured":"Isogai E, Isogai H, Matuo K, Hirose K, Kowashi Y, Okumuara K et al (2003) Sensitivity of genera Porphyromonas and Prevotella to the bactericidal action of C-terminal domain of human CAP18 and its analogues. Oral Microbiol Immunol 18(5):329\u2013332. doi:https:\/\/doi.org\/10.1034\/j.1399-302X.2003.00083.x","journal-title":"Oral Microbiol Immunol"},{"key":"7267_CR30","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.chemphyslip.2011.09.004","volume":"164","author":"S Riedl","year":"2011","unstructured":"Riedl S, Zweytick D, Lohner (2011) K. Membrane-active host defense peptides\u2014Challenges and perspectives for the development of novel anticancer drugs. Chem Phys Lipids 164:766\u2013781. doi:https:\/\/doi.org\/10.1016\/j.chemphyslip.2011.09.004","journal-title":"Chem Phys Lipids"},{"key":"7267_CR31","doi-asserted-by":"publisher","unstructured":"Harris F, Dennison SR, Singh J, Phoenix DA On the selectivity and efficacy of defense peptides with respect to cancer cells.Med Res Rev2013, 33(1):190\u2013234. doi: https:\/\/doi.org\/10.1002\/med.20252","DOI":"10.1002\/med.20252"},{"key":"7267_CR32","doi-asserted-by":"publisher","unstructured":"Simons K, Ikonen E (2000) How cells handle cholesterol. Science 290, 1721\u20131726, doi:https:\/\/doi.org\/10.1126\/science.290.5497.1721","DOI":"10.1126\/science.290.5497.1721"},{"key":"7267_CR33","doi-asserted-by":"publisher","unstructured":"Matsuzaki K, Sugishita K, Fujii N, Miyajima K (1995) Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2. Biochemistry 34, 3423\u20133429, doi:https:\/\/doi.org\/10.1021\/bi00010a034","DOI":"10.1021\/bi00010a034"},{"key":"7267_CR34","doi-asserted-by":"publisher","unstructured":"Wojcik C, Sawicki W, Marianowski P, Benchaib M, Czyba JC, Guerin JF Cyclodextrin enhances spermicidal effects of magainin-2-amide. Contraception 2000, 62, 99\u2013103, doi:https:\/\/doi.org\/10.1016\/S0010-7824(00)00143-8","DOI":"10.1016\/S0010-7824(00)00143-8"},{"key":"7267_CR35","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/0005-2736(88)90069-7","volume":"939","author":"H Steiner","year":"1988","unstructured":"Steiner H, Andreu D, Merrifield RB (1988) Binding and action of cecropin and cecropin analogues: Antibacterial peptides from insects. Biochim Biophys Acta 939:260\u2013266. doi:https:\/\/doi.org\/10.1016\/0005-2736(88)90069-7","journal-title":"Biochim Biophys Acta"},{"key":"7267_CR36","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.pep.2005.10.022","volume":"47","author":"Y Li","year":"2006","unstructured":"Li Y, Li X, Wang G (2006) Cloning, expression, isotope labeling, and purification of human antimicrobial peptide LL-37 in Escherichia coli for NMR studies. Protein Expr Purif 47:498\u2013505","journal-title":"Protein Expr Purif"},{"key":"7267_CR37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ctrv.2014.12.012","volume":"41","author":"GS Higgins","year":"2015","unstructured":"Higgins GS, O\u2019Cathail SM, Muschel R, McKenna WG (2015) Drug radiotherapy combinations: Review of previous failures and reasons for future optimism. Cancer Treat Rev 41:105\u2013113. doi:https:\/\/doi.org\/10.1016\/j.ctrv.2014.12.012","journal-title":"Cancer Treat Rev"},{"key":"7267_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/138161210789941847","volume":"16","author":"A Urruticoechea","year":"2010","unstructured":"Urruticoechea A, Alemany R, Balart J, Villanueva A, Vinals F, Capella G (2010) Recent advances in cancer therapy: An overview. Curr Pharm Des 16:3\u201310. doi:https:\/\/doi.org\/10.2174\/138161210789941847","journal-title":"Curr Pharm Des"},{"issue":"7","key":"7267_CR39","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.ctrv.2014.03.004","volume":"40","author":"EM Ciruelos Gil","year":"2014","unstructured":"Ciruelos Gil EM (2014) Targeting the PI3K\/AKT\/mTOR pathway in estrogen receptor-positive breast cancer. Cancer Treat Rev 40(7):862\u2013871. 10.1016\/j. ctrv.2014.03.004","journal-title":"Cancer Treat Rev"},{"key":"7267_CR40","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1517\/14728214.2015.1051467","volume":"20","author":"B Vincenzi","year":"2015","unstructured":"Vincenzi B, Imperatori M, Silletta M, Marrucci E, Santini D, Tonini G (2015) Emerging kinase inhibitors of the treatment of gastric cancer. Expert Opin Emerg Drugs 20:479\u2013493. doi:https:\/\/doi.org\/10.1517\/14728214.2015.1051467","journal-title":"Expert Opin Emerg Drugs"},{"key":"7267_CR41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5114\/wo.2014.4349544","volume":"19","author":"B Karczmarek-Borowska","year":"2015","unstructured":"Karczmarek-Borowska B, Sa\u0142ek-Za\u0144 A (2015) Hepatotoxicity of molecular targeted therapy. Contemp Oncol 19:87\u201392. https:\/\/doi.org\/10.5114\/wo.2014.4349544","journal-title":"Contemp Oncol"},{"key":"7267_CR42","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1021\/bi051570k","volume":"45","author":"G Ray","year":"2006","unstructured":"Ray G, Dhar G, Van Veldhuizen PJ, Banerjee S, Saxena NK, Sengupta K, Banerjee SK (2006) Modulation of cell-cycle regulatory signaling network by 2-. pathways Biochem 45:3703\u20133713methoxyestradiol in prostate cancer cells is mediated through multiple signal transduction","journal-title":"pathways Biochem"},{"key":"7267_CR43","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.addr.2009.05.0105","volume":"61","author":"D Pathania","year":"2009","unstructured":"Pathania D, Millard M, Neamati N (2009) Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism. Adv Drug Deliv Rev 61:1250\u20131275. doi:https:\/\/doi.org\/10.1016\/j.addr.2009.05.0105","journal-title":"Adv Drug Deliv Rev"},{"key":"7267_CR44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/med.20161","volume":"30","author":"Y Li","year":"2010","unstructured":"Li Y, Cozzi PJ (2010) Angiogenesis as a strategic target for prostate cancer therapy. Med Res Rev 30:23\u201366. doi:https:\/\/doi.org\/10.1002\/med.20161","journal-title":"Med Res Rev"},{"key":"7267_CR45","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2174\/092986710790416254","volume":"17","author":"EC Breen","year":"2010","unstructured":"Breen EC, Walsh J (2010) Tubulin-targeting agents in hybrid drugs. Curr Med Chem 17:609\u2013639. doi:https:\/\/doi.org\/10.2174\/092986710790416254","journal-title":"Curr Med Chem"},{"issue":"1","key":"7267_CR46","doi-asserted-by":"publisher","first-page":"R11","DOI":"10.1111\/j.1750-3841.2011.02455.x54","volume":"77","author":"CC Udenigwe","year":"2012","unstructured":"Udenigwe CC, Aluko RE (2012) Food protein-derived bioactive peptides: production, processing, and potential health benefits. J Food Sci 77(1):R11\u201324. https:\/\/doi.org\/10.1111\/j.1750-3841.2011.02455.x54","journal-title":"J Food Sci"},{"key":"7267_CR47","doi-asserted-by":"publisher","unstructured":"Zheng LH, Wang YJ, Sheng J, Wang F, Zheng Y, Lin XK et al Antitumor peptides from marine organisms.Mar Drugs2011, 9(10):1840\u201359. doi: https:\/\/doi.org\/10.3390\/md910184055","DOI":"10.3390\/md910184055"},{"key":"7267_CR48","first-page":"360","volume":"63","author":"R Smolarczyk","year":"2009","unstructured":"Smolarczyk R, Cichon T, Szala S (2009) [Peptides: a new class of anticancer drugs]. Postepy Hig Med Dosw (Online) 63:360\u2013368","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"7267_CR49","doi-asserted-by":"publisher","unstructured":"Liu W, Min Hu M, Wang Y, Sun B, Guo Y, Xu Z, Li J, Han B Overexpression of interleukin-18 protein reduces viability and induces apoptosis of tongue squamous cell carcinoma cells by activation of glycogen synthase kinase-3\u03b2 signaling 2015, 33(3):1049\u201356. doi: https:\/\/doi.org\/10.3892\/or.2015.3724","DOI":"10.3892\/or.2015.3724"},{"key":"7267_CR50","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1177\/147323001204000215","volume":"40","author":"W Liu","year":"2012","unstructured":"Liu W, Han B, Sun B, Gao Y, Huang Y, Hu M (2012) Overexpression of interleukin-18 induces growth inhibition, apoptosis and gene expression changes in a human tongue squamous cell carcinoma cell line. J Int Med Res 40:537\u2013544","journal-title":"J Int Med Res"},{"key":"7267_CR51","doi-asserted-by":"crossref","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402\u2013408","DOI":"10.1006\/meth.2001.1262"},{"key":"7267_CR52","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12917-016-0866-6","volume":"12","author":"MO Lee","year":"2016","unstructured":"Lee MO, Jang HJ, Rengaraj D, Yang SY, Han JY, Lamont SJ, Womack JE (2016) Tissue expression and antibacterial activity of host defense peptides in chicken. BMC Vet Res 12:231","journal-title":"BMC Vet Res"},{"key":"7267_CR53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.lfs.2016.08.009","volume":"162","author":"FTT Frajacomo","year":"2016","unstructured":"Frajacomo FTT, Padilha C, Marinello PC, Guarnier F, Cecchini R, Duarte JA, Deminice R (2016) Solid Ehrlich carcinoma reproduces functional and biological characteristics of cancer cachexia. Life Sci 162:47\u201353","journal-title":"Life Sci"},{"key":"7267_CR54","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1158\/1541-7786.MCR-08-0274","volume":"7","author":"JS Mader","year":"2009","unstructured":"Mader JS, Mookherjee N, Hancock R, Bleackley RC (2009) The human host defense peptide LL-37 induces apoptosis in a calpain- and apoptosis-inducing factordependent manner involving Bax activity. Mol Cancer Res 7:689\u2013702. doi:https:\/\/doi.org\/10.1158\/1541-7786.MCR-08-0274","journal-title":"Mol Cancer Res"},{"key":"7267_CR55","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jsbmb.2010.02.019","volume":"119","author":"BA Stander","year":"2010","unstructured":"Stander BA, Marais S, Vorster C, Joubert (2010), A.M. In vitro effects of 2-methoxyestradiol on morphology, cell cycle progression, cell death and gene expression changes in the tumorigenic MCF-7 breast epithelial cell line. J Steroid Biochem Mol Biol 119:149\u2013160","journal-title":"J Steroid Biochem Mol Biol"},{"key":"7267_CR56","doi-asserted-by":"publisher","unstructured":"Choi HJ, Zhu BT Critical role of cyclin B1\/Cdc2 up-regulation in the induction of mitotic prometaphase arrest in human breast cancer cells treated with 2-methoxyestradiol.Biochim Biophys Acta2012, 1823(8):1306-15.doi: https:\/\/doi.org\/10.1016\/j.bbamcr.2012.05.003","DOI":"10.1016\/j.bbamcr.2012.05.003"},{"key":"7267_CR57","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1126\/science.2683079","volume":"246","author":"LH Hartwell","year":"1989","unstructured":"Hartwell LH, Weinert TA, Checkpoints (1989) Controls that Ensure the Order of Cell Cycle Events. Science 246:629\u2013634","journal-title":"Science"},{"key":"7267_CR58","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/biom12020258","volume":"12","author":"PV Van Azevedo","year":"2022","unstructured":"Van Azevedo PV, Lopes F, Z\u00f3ia DS, Correia MAP, Saito LIV, Fonseca N, Polloni BB, Teixeira L, Goulart SC (2022) Melo Rodrigues \u00c1vila, V. A New Approach to Inhibiting Triple-Negative Breast Cancer: In Vitro, Ex Vivo and In Vivo Antiangiogenic Effect of BthTx-II, a PLA2-Asp-49 from Bothrops jararacussu Venom. Biomolecules 12:258. https:\/\/doi.org\/10.3390\/biom12020258. de","journal-title":"Biomolecules"},{"issue":"5","key":"7267_CR59","first-page":"635","volume":"56","author":"J Wesierska-Gadek","year":"2004","unstructured":"Wesierska-Gadek J, Gueorguieva M, Wojciechowski J, Horky M (2004) Cell cycle arrest induced in human breast cancer cells by cyclin-dependent kinase inhibitors: a comparison of the effects exerted by roscovitine and olomoucine. Pol J Pharmacol 56(5):635\u2013641","journal-title":"Pol J Pharmacol"},{"key":"7267_CR60","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3892\/or.2012.1876","volume":"28","author":"K Kuroda","year":"2012","unstructured":"Kuroda K, Fukuda T, Yoneyama H, Katayama M, Isogai H, Okumura K, Isogai E (2012) Anti-proliferative effect of an analogue of the LL-37 peptide in the colon cancer derived cell line HCT116 p53+\/+ and p53. Oncol Rep 28:829\u2013834. doi:https:\/\/doi.org\/10.3892\/or.2012.1876","journal-title":"Oncol Rep"},{"key":"7267_CR61","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/S0145-2126(03)00020-189","volume":"27","author":"Y-H Yang","year":"2003","unstructured":"Yang Y-H, Zheng G-G, Li G, Zhang B, Song Y-H, Wu K-F (2003) Expression of LL-37\/hCAP-18 gene in human leukemia cells. Leuk Res 27:947\u2013950. https:\/\/doi.org\/10.1016\/S0145-2126(03)00020-189","journal-title":"Leuk Res"},{"key":"7267_CR62","doi-asserted-by":"publisher","first-page":"e63641","DOI":"10.1371\/journal.pone.0063641","volume":"8","author":"SX Ren","year":"2013","unstructured":"Ren SX, Shen J, Cheng A, Lu L, Chan RLY, Li ZJ, Wang XJ, Wong CCM, Zhang L, Ng SSM et al (2013) FK-16 derived from the anticancer peptide LL-37 induces caspase-independent apoptosis and autophagic cell death in colon cancer cells. PLoS ONE 8:e63641. doi:https:\/\/doi.org\/10.1371\/journal.pone.0063641","journal-title":"PLoS ONE"},{"key":"7267_CR63","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0305-7372(03)00133-6","volume":"29","author":"DM Savarese","year":"2003","unstructured":"Savarese DM, Savy G, Vahdat L, Wischmeyer E, Corey P (2003) Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treat Rev 29:501\u2013513","journal-title":"Cancer Treat Rev"},{"issue":"7","key":"7267_CR64","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1084\/jem.192.7.1069","volume":"192","author":"D Yang","year":"2000","unstructured":"Yang D, Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J, Joost J, Oppenheim, Chertov O (2000) \u201cLL-37, the neutrophil granule\u2013and epithelial cell\u2013derived cathelicidin, utilizes formyl peptide receptor\u2013like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells\u201d. J Exp Med 192(7):1069\u20131074","journal-title":"J Exp Med"},{"issue":"2\u20133","key":"7267_CR65","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/s0300-9084(02)01374-3","volume":"84","author":"C Cand\u00e9","year":"2002","unstructured":"Cand\u00e9 C, Cohen I, Daugas E, Ravagnan L, Larochette N, Zamzami N, Kroemer G (2002) Apoptosis-inducing factor (AIF): a novel caspase-independent death effector released from mitochondria. Biochimie 84(2\u20133):215\u2013222. doi: https:\/\/doi.org\/10.1016\/s0300-9084(02)01374-3","journal-title":"Biochimie"},{"key":"7267_CR66","doi-asserted-by":"crossref","unstructured":"Ni L, Lu JInterferon gamma in cancer immunotherapy.Cancer Medicine2018,7,4509\u20134516","DOI":"10.1002\/cam4.1700"},{"issue":"4","key":"7267_CR67","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1089\/hum.124","volume":"20","author":"CM Chuang","year":"2009","unstructured":"Chuang CM, Monie A, Wu A, Mao CP, Hung CF (2009) Treatment with LL-37 peptide enhances antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancer. Hum Gene Ther 20(4):303\u2013313. 10.1089\/ hum.124","journal-title":"Hum Gene Ther"},{"key":"7267_CR68","doi-asserted-by":"crossref","unstructured":"Bucki R, Leszczy\u0144ska K (2010) Andrzej Namiot, and Wojciech Soko\u0142owski. \u201cCathelicidin LL-37: a multitask antimicrobial peptide.\u201c Archivum immunologiae et therapiae experimentalis58 (1):15\u201325","DOI":"10.1007\/s00005-009-0057-2"},{"key":"7267_CR69","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1242\/jcs.03239","volume":"119","author":"M Bots","year":"2006","unstructured":"Bots M, Medema JP (2006) Granzymes at a glance. J Cell Sci 119:5011\u20135014","journal-title":"J Cell Sci"},{"key":"7267_CR70","doi-asserted-by":"crossref","unstructured":"Mader JS, Catherine Ewen REW, Hancock, Robert C, Bleackley \u201cThe human cathelicidin, LL-37, induces granzyme-mediated apoptosis in regulatory T cells.\u201cJournal of Immunotherapy2011,34 (3):229\u2013235","DOI":"10.1097\/CJI.0b013e318207ecdf"},{"key":"7267_CR71","doi-asserted-by":"crossref","unstructured":"Cheng M, Ho S 1, Yoo JH, Tran DH, Bakirtzi K, Su B, Tran DHY, Kubota IchikawaR, Koon HW (2015) Cathelicidin suppresses colon cancer development by inhibition of cancer associated fibroblasts. Clin Exp Gastroenterol 8:13\u201329","DOI":"10.2147\/CEG.S70906"},{"key":"7267_CR72","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00005-015-0359-5","volume":"64","author":"E Piktel","year":"2016","unstructured":"Piktel E, Niemirowicz K, Wnorowska U, W\u0105tek M, Wollny T, G\u0142uszek K, G\u00f3\u017ad\u017a S, Levental I, Bucki R (2016) The role of cathelicidin LL-37 in cancer development. Arch Immunol Ther Exp 64:33\u201346","journal-title":"Arch Immunol Ther Exp"},{"key":"7267_CR73","doi-asserted-by":"publisher","unstructured":"Wang C, Dong S, Zhang L, Zhao Y, Huang L, Gong X, Wang H, Shang D Cell surface binding, uptaking and anticancer activity of L-K6, a lysine\/leucine-rich peptide, on human breast cancer MCF-7 cells. Scientific Reports 2017,7:8293. DOI: https:\/\/doi.org\/10.1038\/s41598-017-08963-2, PMID: 28811617","DOI":"10.1038\/s41598-017-08963-2"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07267-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-07267-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07267-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T22:57:45Z","timestamp":1657234665000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-07267-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,21]]},"references-count":73,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["7267"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-07267-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,21]]},"assertion":[{"value":"22 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"the Ethics Committee of King Abdulaziz University (Reference No 325\u2009\u2212\u200919).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board Statement"}},{"value":"All the authors declare no conflict of interest. All data used in this study were granted in United States Patent and Trademark office under Patent number (US 11179438B1). The manuscript has submitted as a preprint in Research Square platform under DOI: .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}